Similar articles

• Lessons learned from hyperthermia.

  van der Zee J, Hulshof MC. van der Zee J, et al. Int J Radiat Oncol Biol Phys. 2003 Oct 1;57(2):596-7; author reply 599-600. doi: 10.1016/s0360-3016(03)00419-x. Int J Radiat Oncol Biol Phys. 2003. PMID: 12957277 No abstract available.
• Gene therapy for prostate cancer.

  Gingrich JR, Chauhan RD, Steiner MS. Gingrich JR, et al. Curr Oncol Rep. 2001 Sep;3(5):438-47. doi: 10.1007/s11912-001-0031-6. Curr Oncol Rep. 2001. PMID: 11489246 Review.
• Prospective randomized phase 2 trial of intensity modulated radiation therapy with or without oncolytic adenovirus-mediated cytotoxic gene therapy in intermediate-risk prostate cancer.

  Freytag SO, Stricker H, Lu M, Elshaikh M, Aref I, Pradhan D, Levin K, Kim JH, Peabody J, Siddiqui F, Barton K, Pegg J, Zhang Y, Cheng J, Oja-Tebbe N, Bourgeois R, Gupta N, Lane Z, Rodriguez R, DeWeese T, Movsas B. Freytag SO, et al. Int J Radiat Oncol Biol Phys. 2014 Jun 1;89(2):268-76. doi: 10.1016/j.ijrobp.2014.02.034. Epub 2014 May 5. Int J Radiat Oncol Biol Phys. 2014. PMID: 24837889 Free PMC article. Clinical Trial.
• Phase I/II trial evaluating combined radiotherapy and in situ gene therapy with or without hormonal therapy in the treatment of prostate cancer--a preliminary report.

  Teh BS, Aguilar-Cordova E, Kernen K, Chou CC, Shalev M, Vlachaki MT, Miles B, Kadmon D, Mai WY, Caillouet J, Davis M, Ayala G, Wheeler T, Brady J, Carpenter LS, Lu HH, Chiu JK, Woo SY, Thompson T, Butler EB. Teh BS, et al. Int J Radiat Oncol Biol Phys. 2001 Nov 1;51(3):605-13. doi: 10.1016/s0360-3016(01)01692-3. Int J Radiat Oncol Biol Phys. 2001. PMID: 11597799 Clinical Trial.
• Prostate cancer gene therapy.

  Steiner MS, Gingrich JR, Chauhan RD. Steiner MS, et al. Surg Oncol Clin N Am. 2002 Jul;11(3):607-20. doi: 10.1016/s1055-3207(02)00026-1. Surg Oncol Clin N Am. 2002. PMID: 12487058 Review.